Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

The Medicines Co Prices Public Offering of Common Stock


Tuesday, 13 Aug 2013 07:59pm EDT 

The Medicines Co announced the pricing of an underwritten registered public offering of 5,785,123 shares of its common stock at a public offering price of $30.25 per share. All of the shares in the offering are to be sold by The Medicines Company. The offering is expected to close on or about August 19, 2013. J.P. Morgan Securities LLC and BofA Merrill Lynch are acting as joint book-running managers, and representatives of the underwriters for the offering. Leerink Swann LLC is also acting as a joint book-running manager. The Medicines Company has granted the underwriters a 30-day option to purchase up to an additional 867,768 shares. 

Company Quote

28.71
0.62 +2.21%
4:00pm EDT